Literature DB >> 18327770

Generation and characterization of alpha-chymase-Cre transgenic mice.

Werner Müsch1, Anja K Wege, Daniela N Männel, Thomas Hehlgans.   

Abstract

The Cre-loxP technology allows the introduction of somatic gene alterations in a tissue and/or cell type specific manner. The development of transgenes that target Cre expression to specific cell types is a critical component in this system. Here, we describe the generation and characterization of transgenic mouse lines expressing Cre recombinase under the control of the baboon alpha-chymase promoter, designated Chm:Cre, in order to direct Cre expression specifically to mouse mast cells. Chm:Cre expression was detected in mast cells in lung and colon tissue. Cre-mediated recombination in these mice identified a population of mature tissue resident mast cells using ROSA26R reporter mice. No Cre-expression and Cre-mediated recombination was induced in in vitro generated bone marrow derived mast cells or mast cells isolated from the peritoneal cavity indicating that Cre-expression under the control of the alpha-chymase promoter is solely activated in tissue resident mast cells. These Chm:Cre transgenic mice represent a useful tool to specifically inactivate genes of interest in mast cells of these tissues. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327770     DOI: 10.1002/dvg.20378

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  18 in total

Review 1.  Biological implications of preformed mast cell mediators.

Authors:  Anders Lundequist; Gunnar Pejler
Journal:  Cell Mol Life Sci       Date:  2010-11-11       Impact factor: 9.261

Review 2.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

3.  Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice.

Authors:  Clare L Abram; Gray L Roberge; Yongmei Hu; Clifford A Lowell
Journal:  J Immunol Methods       Date:  2014-05-22       Impact factor: 2.303

Review 4.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

Review 5.  Protective and pathological roles of mast cells and basophils.

Authors:  David Voehringer
Journal:  Nat Rev Immunol       Date:  2013-04-05       Impact factor: 53.106

Review 6.  Roles of basophils and mast cells in cutaneous inflammation.

Authors:  Atsushi Otsuka; Yumi Nonomura; Kenji Kabashima
Journal:  Semin Immunopathol       Date:  2016-05-11       Impact factor: 9.623

Review 7.  Mast cell mediators in tolerance.

Authors:  Victor C de Vries; Randolph J Noelle
Journal:  Curr Opin Immunol       Date:  2010-09-29       Impact factor: 7.486

Review 8.  Mast cells as regulators of adaptive immunity to tumours.

Authors:  A Wasiuk; V C de Vries; K Hartmann; A Roers; R J Noelle
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

Review 9.  New developments in mast cell biology.

Authors:  Janet Kalesnikoff; Stephen J Galli
Journal:  Nat Immunol       Date:  2008-11       Impact factor: 25.606

Review 10.  New models for analyzing mast cell functions in vivo.

Authors:  Laurent L Reber; Thomas Marichal; Stephen J Galli
Journal:  Trends Immunol       Date:  2012-11-02       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.